• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诺氟沙星、阿莫西林、复方新诺明和萘啶酸。治疗尿路感染的3天和7天疗法研究综述。

Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.

作者信息

Vogel R, Deaney N B, Round E M, VandenBurg M J, Currie W J

出版信息

J Antimicrob Chemother. 1984 May;13 Suppl B:113-20. doi: 10.1093/jac/13.suppl_b.113.

DOI:10.1093/jac/13.suppl_b.113
PMID:6234271
Abstract

The results of clinical trials in which norfloxacin was used for 7 days compared with amoxycillin or cotrimoxazole, or for 3 days compared with citrated nalidixic acid, are presented. Additionally, the results of a concurrent open study of 3 days of norfloxacin in the management of simple urinary tract infections are discussed. Resistance to norfloxacin was only encountered in 0.2% of pathogens isolated. Norfloxacin was as effective in eradicating bacteriuria as amoxycillin, cotrimoxazole or citrated nalidixic acid. The response to 3 days of norfloxacin was similar to that seen after 7 days therapy with this compound, or to 7 days of cotrimoxazole. The incidence of adverse experiences to norfloxacin in 758 patients was below 10%.

摘要

本文展示了诺氟沙星与阿莫西林或复方新诺明相比使用7天,以及与枸橼酸萘啶酸相比使用3天的临床试验结果。此外,还讨论了一项关于诺氟沙星治疗单纯性尿路感染3天的同期开放性研究结果。分离出的病原体中仅0.2%对诺氟沙星耐药。诺氟沙星在根除菌尿方面与阿莫西林、复方新诺明或枸橼酸萘啶酸同样有效。使用诺氟沙星3天的效果与使用该化合物7天的效果相似,或与使用复方新诺明7天的效果相似。758例患者中诺氟沙星不良反应的发生率低于10%。

相似文献

1
Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.诺氟沙星、阿莫西林、复方新诺明和萘啶酸。治疗尿路感染的3天和7天疗法研究综述。
J Antimicrob Chemother. 1984 May;13 Suppl B:113-20. doi: 10.1093/jac/13.suppl_b.113.
2
Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial.诺氟沙星与复方新诺明治疗单纯性尿路感染的多中心试验
J Antimicrob Chemother. 1984 May;13 Suppl B:89-94. doi: 10.1093/jac/13.suppl_b.89.
3
Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections.诺氟沙星与复方新诺明治疗尿路感染的临床评估
Eur J Clin Microbiol. 1983 Jun;2(3):260-5. doi: 10.1007/BF02029529.
4
Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections.诺氟沙星与复方新诺明治疗下尿路感染的比较
Eur J Clin Microbiol. 1983 Jun;2(3):266-9. doi: 10.1007/BF02029530.
5
Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.诺氟沙星与甲氧苄啶-磺胺甲恶唑治疗女性局部急性症状性尿路感染的对比试验及其对尿道周围和粪便微生物群的抗菌作用
Antimicrob Agents Chemother. 1984 Oct;26(4):481-4. doi: 10.1128/AAC.26.4.481.
6
A review of urinary tract infection in the elderly.
J Antimicrob Chemother. 1984 May;13 Suppl B:69-78. doi: 10.1093/jac/13.suppl_b.69.
7
Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora.诺氟沙星在尿路感染中的疗效及对阴道和粪便菌群的生物学效应。
J Urol. 1985 Apr;133(4):628-30. doi: 10.1016/s0022-5347(17)49118-x.
8
The antimicrobial spectrum of norfloxacin.诺氟沙星的抗菌谱。
J Antimicrob Chemother. 1984 May;13 Suppl B:25-31. doi: 10.1093/jac/13.suppl_b.25.
9
Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.诺氟沙星与甲氧苄啶-磺胺甲恶唑治疗非复杂性社区获得性尿路感染的疗效比较
Antimicrob Agents Chemother. 1985 Mar;27(3):422-3. doi: 10.1128/AAC.27.3.422.
10
Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.诺氟沙星与阿莫西林治疗老年患者复杂性尿路感染的对比研究。
J Antimicrob Chemother. 1984 May;13 Suppl B:79-83. doi: 10.1093/jac/13.suppl_b.79.

引用本文的文献

1
Comparison of norfloxacin versus nalidixic acid in therapy of acute urinary tract infections.诺氟沙星与萘啶酸治疗急性尿路感染的比较。
Can J Infect Dis. 1990 Summer;1(2):35-40. doi: 10.1155/1990/482960.
2
Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women.老年女性单纯性、有症状下尿路感染的抗生素治疗疗程
Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD001535. doi: 10.1002/14651858.CD001535.pub2.
3
Quinolones for uncomplicated acute cystitis in women.喹诺酮类药物用于治疗女性单纯性急性膀胱炎。
Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD003597. doi: 10.1002/14651858.CD003597.pub2.
4
Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.诺氟沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1985 Dec;30(6):482-513. doi: 10.2165/00003495-198530060-00003.
5
Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.氟喹诺酮类。对其作用方式、抗菌活性、药代动力学及临床疗效的综述。
Pharm Weekbl Sci. 1986 Feb 21;8(1):1-21. doi: 10.1007/BF01975473.
6
[Clinical study of the effectiveness and tolerance of norfloxacin in the therapy of complicated urinary tract infections and in long-term prevention of recurrent urinary tract infections].诺氟沙星治疗复杂性尿路感染及长期预防复发性尿路感染的有效性与耐受性的临床研究
Infection. 1987 Jan-Feb;15(1):20-4. doi: 10.1007/BF01646113.
7
Norfloxacin: a new quinolone. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.诺氟沙星:一种新型喹诺酮类药物。加拿大传染病协会抗菌药物委员会。
CMAJ. 1988 Aug 15;139(4):305-7.
8
New 4-quinolones in the treatment of urinary tract infections.
Pharm Weekbl Sci. 1986 Feb 21;8(1):46-52. doi: 10.1007/BF01975480.
9
Quinolone antibacterial agents for the treatment of genitourinary tract infections.用于治疗泌尿生殖道感染的喹诺酮类抗菌剂。
Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1111-6. doi: 10.1007/BF01975178.
10
Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.氟喹诺酮类药物治疗泌尿生殖道感染:体外活性、药代动力学及在尿路感染和前列腺炎中的临床疗效
Antimicrob Agents Chemother. 1989 Oct;33(10):1655-61. doi: 10.1128/AAC.33.10.1655.